Citadel Advisors - TONIX PHARMACEUTICALS HLDG C ownership

TONIX PHARMACEUTICALS HLDG C's ticker is and the CUSIP is 890260951. A total of 2 filers reported holding TONIX PHARMACEUTICALS HLDG C in Q2 2015. The put-call ratio across all filers is - and the average weighting 0.0%.

Quarter-by-quarter ownership
Citadel Advisors ownership history of TONIX PHARMACEUTICALS HLDG C
ValueSharesWeighting
Q2 2016$40,000
+42.9%
20,300
+463.9%
0.00%
Q4 2015$28,000
+40.0%
3,600
-2.7%
0.00%
Q3 2015$20,000
-4.8%
3,700
+60.9%
0.00%
Q2 2015$21,000
+320.0%
2,300
+187.5%
0.00%
Q1 2015$5,000
+400.0%
800
+300.0%
0.00%
Q4 2014$1,0002000.00%
Other shareholders
TONIX PHARMACEUTICALS HLDG C shareholders Q2 2015
NameSharesValueWeighting ↓
Citadel Advisors 2,300$21,0000.00%
SIMPLEX TRADING, LLC 11$1,0000.00%
View complete list of TONIX PHARMACEUTICALS HLDG C shareholders